Debiopharm, Ipsen sales and marketing update

The companies expanded IPN's marketing rights to Debiopharm's Decapeptyl triptorelin pamoate to treat prostate cancer. IPN now has exclusive, worldwide rights excluding the U.S., Sweden, Israel, Ira...